Human alpha galactosidase and alpha 1,2 fucosyltransferase concordantly inhibit xenoreactivity of NIH 3T3 cells with human serum
- PMID: 12956935
Human alpha galactosidase and alpha 1,2 fucosyltransferase concordantly inhibit xenoreactivity of NIH 3T3 cells with human serum
Abstract
Aim: To study the influence of the expression of human alpha galactosidase and alpha1,2 fucosyltransferase on Gal alpha 1,3 Gal and consequent xenoreactivity in NIH3T3 cells.
Methods: The expression levels of G antigen and H antigen and binding of human natural antibodies (IgG and IgM) and complement (C3c) to NIH3T3 cells were analyzed by flow cytometry. Western blot was employed to further determine the expression of glycoproteins of G antigen. Cytolysis assay with normal human serum was performed by MTT assay.
Results: Western blot showed that glycoproteins with molecular weight of 107 kDa, 98 kDa, 88 kDa, 56 kDa, 40 kDa, and 37 kDa were inhibited and even abrogated totally in alpha galactosidase transfectants and alpha 1,2 fucosyltransferase transfectants. The combined transfection of the two enzymes led to a much stronger inhibition of the glycoproteins. The binding of GS-IB4 was decreased by 57.4 % in alpha galactosidase transfectants, 28.8 % in alpha 1,2 fucosyltransferase transfectants, and 72.1 % in combined transfectants, respectively. In contrast, UEA-1 binding was increased about 6.7-fold, 6.0-fold, and 8.0-fold respectively. The xenoreactivity with human IgG was also reduced by 61.4 %, 67.0 %, and 73.4 %, respectively in the three kinds of transfectants. The resistance to cytolysis mediated by human serum was enhanced by 42.4 % in alpha galactosidase transfectants, 51.9 % in alpha 1,2 fucosyltranferase, and even 65.5 % in the combined transfectants.
Conclusion: Although alpha galactosidase and alpha 1,2 fucosyltransferase had different biochemical properties, they could inhibit the expression of Gal alpha 1,3 Gal synergistically, leading to stronger resistance of xenograft against cytolysis.
Similar articles
-
Expression of human alpha-galactosidase leads to reduction of major xenoepitope Galalpha(1,3) Gal in NIH 3T3 cell.Acta Pharmacol Sin. 2003 Oct;24(10):985-90. Acta Pharmacol Sin. 2003. PMID: 14531939
-
Adenovirus-mediated expression of human secretor type alpha(1,2) fucosyltransferase reduces level of Gal alpha(1,3)Gal epitope.Acta Pharmacol Sin. 2000 Sep;21(9):807-13. Acta Pharmacol Sin. 2000. PMID: 11501162
-
Expression of human alpha-galactosidase and alpha1,2-fucosyltransferase genes modifies the cell surface Galalpha1,3Gal antigen and confers resistance to human serum-mediated cytolysis.Chin Med Sci J. 2004 Mar;19(1):31-7. Chin Med Sci J. 2004. PMID: 15104222
-
Adenovirus-mediated expression of antisense RNA transcripts complementary to pig alpha(1,3) galactosyltransferase mRNA inhibits expression of Gal alpha(1,3) Gal epitope.Acta Pharmacol Sin. 2000 Nov;21(11):1005-10. Acta Pharmacol Sin. 2000. PMID: 11501054
-
Xenotransplantation and ABO incompatible transplantation: the similarities they share.Transfus Apher Sci. 2006 Aug;35(1):45-58. doi: 10.1016/j.transci.2006.05.007. Epub 2006 Aug 14. Transfus Apher Sci. 2006. PMID: 16905361 Review.
Cited by
-
Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system.Mol Biotechnol. 2004 Nov;28(3):241-55. doi: 10.1385/MB:28:3:241. Mol Biotechnol. 2004. PMID: 15542924 Review.
-
Extracellular α-Galactosidase from Trichoderma sp. (WF-3): Optimization of Enzyme Production and Biochemical Characterization.Biotechnol Res Int. 2015;2015:860343. doi: 10.1155/2015/860343. Epub 2015 Nov 2. Biotechnol Res Int. 2015. PMID: 26609435 Free PMC article.
-
Immune modulation in xenotransplantation.Arch Immunol Ther Exp (Warsz). 2015 Jun;63(3):181-92. doi: 10.1007/s00005-014-0317-7. Epub 2014 Oct 30. Arch Immunol Ther Exp (Warsz). 2015. PMID: 25354539 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources